Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow ...

Illumina, Inc. ILMN recently acquired Fluent BioSciences, a developer of innovative single-cell technology. This strategic acquisition marks a significant step in Illumina's expansion within the ...

Illumina, Inc. (NASDAQ: ILMN), a ... to detect cell types often missed with ... Illumina's leading sequencing and informatics solutions including Partek Flow, which enables single-cell multiomic ...

In addition, Illumina announced the rebranded commercial debut of its recently acquired single-cell prep system—born out of its purchase of Fluent BioSciences last July, for $85 million in cash ...

Illumina Single-Cell Prep . Also announced today, Illumina Single-Cell Prep, formerly Fluent PipSeq V, is now available and shipping to customers with broad compatibility across Illumina's NGS ...

Accessible, highly scalable single-cell technology expands Illumina's multiomics capabilities. SAN DIEGO, July 9, 2024 /PRNewswire/ -- Illumina, Inc. (), a global leader in DNA sequencing and ...

Illumina, Inc. ILMN recently acquired Fluent BioSciences, a developer of innovative single-cell technology. This strategic acquisition marks a significant step in Illumina's expansion within the ...

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell system alongside a ...

Software upgrade advances complete workflow solutions New NovaSeq X 25B 100-cycle and 200-cycle kits enhance multiomic capabilities on NovaSeq X, and enable newly released Illumina Single-Cell ...

Software upgrade advances complete workflow solutions New NovaSeq X 25B 100-cycle and 200-cycle kits enhance multiomic capabilities on NovaSeq X, and enable newly released Illumina Single-Cell ...